Literature DB >> 12591009

Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells.

R Dziak1, B M Yang, B W Leung, S Li, N Marzec, J Margarone, L Bobek.   

Abstract

The effects of the lysophospholipids, sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) were studied in human primary osteoblastic cells and the human osteosarcomal cell lines, G292 and MG-63. The studies focused on the role of the Gi protein in the regulation of S1P and LPA-induced proliferation, the effects of the phospholipids on alkaline phosphatase, an early marker of osteoblastic cell proliferation, and the presence of edg receptors. Proliferation was assessed by 3H-thymidine incorporation. Short-term incubation with S1P or LPA induced increases in proliferation that were attenuated in the presence of the Gi inhibitor, pertussis toxin. Alkaline phosphatase activity was measured with a spectrophotometric assay. Biphasic effects of S1P and LPA were observed with the nature of the response dependent upon the cell type, concentration of test agent and the time period of incubation. RTPCR studies revealed that edg-1,2,4,5 receptors are present in the primary normal osteoblastic cells, the MG63 and G292 cells. Only the G292 cells expressed the edg-3 receptor to any significant extent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591009     DOI: 10.1016/s0952-3278(02)00277-6

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  11 in total

1.  Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowth.

Authors:  Katrina M Waters; Jon M Jacobs; Marina A Gritsenko; Norman J Karin
Journal:  Bone       Date:  2011-02-26       Impact factor: 4.398

Review 2.  Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.

Authors:  Bernard Y K Binder; Priscilla A Williams; Eduardo A Silva; J Kent Leach
Journal:  Tissue Eng Part B Rev       Date:  2015-07-14       Impact factor: 6.389

3.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

Review 4.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 5.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

6.  Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Kristen A Wieghaus; Edward A Botchwey
Journal:  Biomaterials       Date:  2008-04-11       Impact factor: 12.479

7.  LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)/Egr-1 axis.

Authors:  Werner Windischhofer; Evelyn Huber; Christine Rossmann; Michaela Semlitsch; Kerstin Kitz; Anamaria Rauh; Trevor Devaney; Hans-Jörg Leis; Ernst Malle
Journal:  Biochimie       Date:  2012-05-29       Impact factor: 4.079

8.  Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation.

Authors:  Susan M Millard; Alyssa M Louie; Lalita Wattanachanya; Thomas J Wronski; Bruce R Conklin; Robert A Nissenson
Journal:  J Bone Miner Res       Date:  2011-04       Impact factor: 6.741

9.  Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo.

Authors:  Zi-Li Yu; Bin-Fang Jiao; Zu-Bing Li
Journal:  Biomed Res Int       Date:  2018-05-29       Impact factor: 3.411

10.  Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner.

Authors:  Haonan Liu; Molly L Jackson; Lucy J Goudswaard; Samantha F Moore; James L Hutchinson; Ingeborg Hers
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.